Aromatized liposomes for sustained drug delivery DOI Creative Commons
Yang Li, Tianjiao Ji, Matthew Torre

et al.

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: Oct. 20, 2023

Abstract Insufficient drug loading and leakage of payload remain major challenges in designing liposome-based delivery systems. These phenomena can limit duration effect cause toxicity. Targeting the rate-limiting step release from liposomes, we modify (aromatized) them to have aromatic groups within their lipid bilayers. Aromatized liposomes are designed with synthetic phospholipids covalently conjugated onto acyl chains. The optimized aromatized liposome increases significantly decreases burst a broad range payloads (small molecules macromolecules, different degrees hydrophilicity) extends release. encapsulating anesthetic tetrodotoxin (TTX) achieve markedly prolonged decreased toxicity an application where used clinically: local anesthesia, even though TTX is hydrophilic small molecule which typically difficult encapsulate. Aromatization bilayers improve performance liposomal

Language: Английский

Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases DOI

Menghang Zu,

Ya Ma,

Brandon Cannup

et al.

Advanced Drug Delivery Reviews, Journal Year: 2021, Volume and Issue: 176, P. 113887 - 113887

Published: July 24, 2021

Language: Английский

Citations

130

Stimulus-responsive self-assembled prodrugs in cancer therapy DOI Creative Commons
Xiao Dong, Rajeev Kungur Brahma, Chao Fang

et al.

Chemical Science, Journal Year: 2022, Volume and Issue: 13(15), P. 4239 - 4269

Published: Jan. 1, 2022

Small-molecule prodrugs have become the main toolbox to improve unfavorable physicochemical properties of potential therapeutic compounds in contemporary anti-cancer drug development. Many approved small-molecule prodrugs, however, still face key challenges their pharmacokinetic (PK) and pharmacodynamic (PD) properties, thus severely restricting further clinical applications. Self-assembled emerged as they could take advantage benefits both prodrug design nanomedicine, so maximize loading, reduce premature leakage, PK/PD parameters targeting ability. Notably, temporally spatially controlled release drugs at cancerous sites be achieved by encoding various activable linkers that are sensitive chemical or biological stimuli tumor microenvironment (TME). In this review, we comprehensively summarized recent progress made development single/multiple-stimulus-responsive self-assembled for mono- combinatorial therapy. A special focus was placed on conjugation strategies (polymer-drug conjugates, drug-drug

Language: Английский

Citations

84

Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma DOI
Alexandre Detappe,

Hung V.-T. Nguyen,

Yivan Jiang

et al.

Nature Nanotechnology, Journal Year: 2023, Volume and Issue: 18(2), P. 184 - 192

Published: Jan. 26, 2023

Language: Английский

Citations

70

Polymeric nanoparticles (PNPs) for oral delivery of insulin DOI Creative Commons
Yunyun Wang, Hao Li, Aamir Rasool

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Jan. 3, 2024

Abstract Successful oral insulin administration can considerably enhance the quality of life (QOL) diabetes patients who must frequently take injections. Oral administration, on other hand, is seriously hampered by gastrointestinal enzymes, wide pH range, mucus and mucosal layers, which limit bioavailability to ≤ 2%. Therefore, a large number technological solutions have been proposed increase insulin, in polymeric nanoparticles (PNPs) are highly promising for delivery. The recently published research articles chosen this review based applications PNPs with strong future potential delivery, do not cover all related work. In review, we will summarize controlled release mechanisms latest delivery nanocarrier, challenges prospect. This serve as guide investigators wish engineer study systems. Graphical

Language: Английский

Citations

57

Aromatized liposomes for sustained drug delivery DOI Creative Commons
Yang Li, Tianjiao Ji, Matthew Torre

et al.

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: Oct. 20, 2023

Abstract Insufficient drug loading and leakage of payload remain major challenges in designing liposome-based delivery systems. These phenomena can limit duration effect cause toxicity. Targeting the rate-limiting step release from liposomes, we modify (aromatized) them to have aromatic groups within their lipid bilayers. Aromatized liposomes are designed with synthetic phospholipids covalently conjugated onto acyl chains. The optimized aromatized liposome increases significantly decreases burst a broad range payloads (small molecules macromolecules, different degrees hydrophilicity) extends release. encapsulating anesthetic tetrodotoxin (TTX) achieve markedly prolonged decreased toxicity an application where used clinically: local anesthesia, even though TTX is hydrophilic small molecule which typically difficult encapsulate. Aromatization bilayers improve performance liposomal

Language: Английский

Citations

54